PAPAVERINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H21NO4
Molecular Weight	339.385
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PAPAVERINE

Structure Search

SMILES

COC1=C(OC)C=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1

InChI

InChIKey=XQYZDYMELSJDRZ-UHFFFAOYSA-N

InChI=1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3

HIDE SMILES / InChI

Molecular Formula	C20H21NO4
Molecular Weight	339.385
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:20:09 UTC 2023` Edited by `admin` on `Fri Dec 15 15:20:09 UTC 2023`
Record UNII	DAA13NKG2Q
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PAPAVERINE

Common Name

English

PAPAVERINE [MART.]

Common Name

English

PAPAVERINUM

Common Name

English

PAPAVERINUM [HPUS]

Common Name

English

NSC-136630

Code

English

6,7-DIMETHOXY-1-VERATRYLISOQUINOLINE

Systematic Name

English

ISOQUINOLINE, 1-((3,4-DIMETHOXYPHENYL)METHYL)-6,7-DIMETHOXY-

Systematic Name

English

NOSCAPINE IMPURITY A [EP IMPURITY]

Common Name

English

PAPAVERINE [MI]

Common Name

English

Papaverine [WHO-DD]

Common Name

English

PAPAVERINE [VANDF]

Common Name

English

Classification Tree Code System Code

WHO-VATC

QG04BE02

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

WHO-ATC

G04BE52

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

FDA ORPHAN DRUG

64991

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

NCI_THESAURUS

C29707

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

FDA ORPHAN DRUG

581417

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

WHO-ATC

G04BE02

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

WHO-VATC

QA03AD01

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

WHO-VATC

QG04BE52

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

LIVERTOX

739

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

WHO-ATC

A03AD01

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

NCI_THESAURUS

C744

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

Code System Code Type Description

RXCUI

7895

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

RxNorm

WIKIPEDIA

PAPAVERINE

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

NCI_THESAURUS

C726

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

DRUG CENTRAL

2056

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

DRUG BANK

DB01113

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

CAS

58-74-2

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

DAILYMED

DAA13NKG2Q

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

MESH

D010208

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

PUBCHEM

4680

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

HSDB

3147

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

ECHA (EC/EINECS)

200-397-2

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

EVMPD

SUB14760MIG

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

EPA CompTox

DTXSID4023418

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

ChEMBL

CHEMBL19224

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

FDA UNII

DAA13NKG2Q

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

SMS_ID

100000079721

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

MERCK INDEX

m8392

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

Merck Index

NSC

136630

Created by admin on Fri Dec 15 15:20:09 UTC 2023 , Edited by admin on Fri Dec 15 15:20:09 UTC 2023

PRIMARY

Related Record Type Details


					23473EC6BQ

PAPAVERINE HYDROCHLORIDE

SALT/SOLVATE -> PARENT


					91M28639H5

PAPAVERINE HYDROBROMIDE

PARENT -> SALT/SOLVATE


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					7A476JZB2T

PAPAVERINE SULFATE

SALT/SOLVATE -> PARENT

Related Record Type Details


					8V32U4AOQU

NOSCAPINE

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

Related Record Type Details


					DAA13NKG2Q

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC